Prostate cancer is the most common form of cancer in male in Sweden. Researchers at Umeå University in Sweden have now discovered a faster and easier way to determine who has an aggressive form of cancer, and who has not.
“This may have great implications on precision medicine when treating prostate cancer, and on more cancer groups alike,” says Maréne Landström, Professor of Pathology at Umeå
Researchers at Umeå and Uppsala University in Sweden have discovered a new signaling pathway that makes cancer cells aggressive. The findings could lead to improved treatment for advanced prostate cancer, as well as breast and lung cancer.
Cannabis-like substances that are produced by the body have both therapeutic and harmful properties, besides their well-known intoxicating effects, and the body’s cannabinoid system may be a target for new strategies in cancer treatment. This is what Sofia Gustafsson finds in the dissertation she will be defending at Umeå University in Sweden.
Using a strategy based on treating cancer cells that carry a specific genetic signature – hyper-expression of the protein Myc – with therapy that affects the stability of the cell’s DNA, more effective results can be achieved. This was discovered by Andreas Höglund in his dissertation to be publicly defended at Umeå University on September 9.